Journal profile · Medicine-Surgery
EJVES Vascular Forum
ISSN 2666-688X · Elsevier · United Kingdom
EJVES Vascular Forum: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.8 (journal website); fully open access; APC about USD 2,250; median 117 days to acceptance (101 articles, last 24 months); 70 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
EJVES Vascular Forum is published by Elsevier and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Aortic aneurysm repair treatments, Aortic Disease and Treatment Approaches and Peripheral Artery Disease Management, together about 37.6% of its articles. Its main subfields are Pulmonary and Respiratory Medicine and Surgery. (generated from OpenAlex topic counts and CAS ranking data)
Official Journal of the European Society for Vascular SurgeryEJVES Vascular Forum (EJVES VF) is an online only, open access resource aimed at vascular surgeons and other physicians dealing with patients with arterial, venous and lymphatic diseases. The main focus of the journal is to provide an inclusive multimedia platform for education, dissemination of scientific contents, discussion and opinion formation.EJVES Vascular Forum belongs to the European Society For Vascular Surgery (ESVS), which was founded on May 6, 1987 "to relieve sickness and to preserve and protect health by advancing for the public benefit the science and art and research into vascular disease including vascular surgery". The ESVS owns two journals, EJVES (European Journal of Vascular and Endovascular Surgery) and EJVES VF. Both interact closely and have complementary scopes and goals.Whereas EJVES is the main scientific outlet of the ESVS aiming at the best possible Impact Factor (IF), EJVES VF is dedicated to delivering and promoting education and practical knowledge to the community by refining scientific and educational contents related to the ESVS (including the ESVS Annual Meeting, ESVS Academy, ESVS Masterclasses, ESVS Virtual Vascular, and more). It is PubMed listed and will generate its own IF, but its main goal is the dissemination of its contents as measured by downloads, views, clicks, social media references, etc.Contributions are encouraged on the diagnosis, investigation and management of vascular disorders, including scientific research and practical technical aspects of open vascular and endovascular procedures. The journal includes invited state-of-the-art articles and podcasts and provides critical appraisal articles of previously published research. Contributions are also welcome from associated specialities such as cardiovascular surgery, radiology, angiology, diabetology, rehabilitation and other fundamental sciences, provided these relate to the management of vascular patients.The journal publishes case reports, technical reports, position papers, original research, abstracts from Annual Meetings, visual and/or extended abstracts from seminal publications in the field, literature reviews, but also podcasts and videos. Authors are encouraged to submit cases and supplementary materials in video format. In addition, it engages in social media interactions with the community on behalf of ESVS and EJVES, including interactive pdfs of the published papers, guided discussion forums, promotional tweets and rapid response platforms.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Surgery
Editor-in-chief Arindam ChaudhuriPublisher website
Editorial board by country: none in mainland China; most named United Kingdom 5, France 4, Italy 4, United States 2, Spain 2 (23 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Aortic aneurysm repair treatmentsMedicine17.3%
- Aortic Disease and Treatment ApproachesMedicine10.7%
- Peripheral Artery Disease ManagementMedicine9.6%
- Vascular Procedures and ComplicationsMedicine8.6%
- Infectious Aortic and Vascular ConditionsMedicine8.2%
- Cerebrovascular and Carotid Artery DiseasesMedicine4.9%
- Cardiac, Anesthesia and Surgical OutcomesMedicine4.7%
- Central Venous Catheters and HemodialysisHealth Professions4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
| Minor | Surgery | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Surgery | Zone 4 |
| Minor | Peripheral Vascular Disease | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
Other: Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 1.8Publisher website ·
- CiteScore 2026-06
- 2.3LetPub ·
- CiteScore (publisher)
- 2.3Publisher website ·
- SJR 2026-06
- 0.29LetPub ·
- SNIP 2026-06
- 0.7LetPub ·
- h-index
- 14OpenAlex ·
- i10-index
- 24OpenAlex ·
- 2-year mean citedness
- 0.84OpenAlex ·
- Self-citation rate
- 5.6%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 42LetPub ·
Articles by year OpenAlex count · 686 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 52 | 52 | 12 |
| 2025 | 70 | 70 | 74 |
| 2024 | 152 | 152 | 145 |
| 2023 | 93 | 93 | 226 |
| 2022 | 152 | 152 | 245 |
| 2021 | 78 | 78 | 203 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
117 daysMedian, submission to acceptance · P25–P75 71 days – 182 days
- Acceptance to online
- median 7 days (101 articles)
- Submission to online
- median 124 days
- Sample
- 101 articles with submission and acceptance dates (121 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 27 weeksLetPub ·
- Submission to acceptance
- 109 daysPublisher website ·
- Acceptance to publication
- 6 daysPublisher website ·
- Submission to publication (journal-reported)
- about 28 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,250 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 2,045 / EUR 1,910 / GBP 1,640 / JPY 253,640 | — | — | |
| LetPub | USD 1,630 | Yes | — | |
| Publisher website | USD 2,250 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted13, with length limits
- case reportOriginal Research: We welcome the submission of original research in EJVES Vascular Forum. Articles should be formatted to fit in the following format: structur…main text ≤ 1,500 words
- case reports/short reportsCase Reports/Short Reports: Maximum length 1,500 words, structured as Introduction, Report and Discussion.Length not stated
- commentaryOriginal Research: We welcome the submission of original research in EJVES Vascular Forum. Articles should be formatted to fit in the following format: structur…Length not stated
- correspondenceCorrespondence: Relating to papers recently published in the Journal, or containing brief reports of unusual or preliminary findings.Length not stated
- editorialsEditorials: These are usually invited but we will consider unsolicited submissions if they address a current general and important problem, new developments or …Length not stated
- imageImage: The journal will publish interesting images that support its aims and scope.Length not stated
- invited commentariesInvited commentaries: Maximum length 750 words, no specific structure, 1 table/figure maximum, no more than 10 references.Length not stated
- original researchOriginal Research: We welcome the submission of original research in EJVES Vascular Forum. Articles should be formatted to fit in the following format: structur…Length not stated
- review articleOriginal Research: We welcome the submission of original research in EJVES Vascular Forum. Articles should be formatted to fit in the following format: structur…main text ≤ 3,000 words
- review articlesReview Articles: Maximum length of 3,000 words (excluding references), maximum 40 references, with a structured abstract of 300 words and a maximum of 5 figures…Length not stated
- surgical videosSurgical Videos: We encourage the submission of technical videos.Length not stated
- technical noteOriginal Research: We welcome the submission of original research in EJVES Vascular Forum. Articles should be formatted to fit in the following format: structur…main text ≤ 1,500 words
- technical notesTechnical Notes: Maximum length 1,500 words, structured as Introduction, Technique and Discussion (highlighting advantages, important considerations, pitfalls a…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Plagiarism, Preprints
- Authorship Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the article or revising it critically for important intellectual content, (3) final approval of the version to be submitted.
Source ↗Publisher website ·- Conflicts of interest Declaration of interest
Competing interests statement required Model summary
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…
Source ↗Publisher website ·- Publication ethics
Human subjects research must comply with ethical standards Model summary
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance wi
Source ↗Publisher website ·- License & copyright Copyright
Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (see more information on this). Permitted third party reuse of open access articles is determined by the author's choice of user license.Author rightsAs an author you (or your employer or institution) have certain rights to reuse your work. More information.
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page for more information about open access publishing in this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process Model summary
This journal operates a single anonymized review process. All contributions are assessed by the Editors and may be sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper.
Source ↗Publisher website ·- Plagiarism
Crossref Similarity Check for plagiarism Model summary
To verify compliance, your article may be checked by Crossref Similarity Check and other originality or duplicate checking software.
Source ↗Publisher website ·- Preprints Preprint references
Where a preprint has subsequently become available as a peer-reviewed publication, the formal publication should be used as the reference. If there are preprints that are central to your work or that cover crucial developments in the topic, but are not yet formally published, these may be referenced. Preprints should be clearly marked as such, for example by including the word preprint, or the nam…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2666-688X
- Society / sponsor
- European Society for Vascular Surgery
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about EJVES Vascular Forum
What CAS zone is EJVES Vascular Forum in?
In the 2025 upgraded edition of the CAS Journal Ranking, EJVES Vascular Forum is in Zone 4 of Medicine, and in Zone 4 of the minor category Peripheral Vascular Disease / Surgery. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of EJVES Vascular Forum?
The journal's website gives an impact factor of 1.8; this is the journal's own figure, as LetPub lists none for it; CiteScore 2.3, h-index 14.
How long does peer review take at EJVES Vascular Forum?
Based on the dates recorded on 101 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 117 days (interquartile range 71–182 days); authors report an average review time of about 27 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of EJVES Vascular Forum based?
Of the 23 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United Kingdom (5), France (4) and Italy (4). Counted from the institutions listed on the board page; for reference only.
Which databases index EJVES Vascular Forum?
According to LetPub and DOAJ records, EJVES Vascular Forum is indexed in ESCI, Scopus and DOAJ. The journal's website also lists PubMed; that list has not been checked against each database.
Is EJVES Vascular Forum open access, and what is the APC?
EJVES Vascular Forum is a fully open-access journal. APC about USD 2,250.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-30). Last updated: .